TH152829A - Please love the adrenomedulin polyethylene glycol base and its use. - Google Patents
Please love the adrenomedulin polyethylene glycol base and its use.Info
- Publication number
- TH152829A TH152829A TH1401002360A TH1401002360A TH152829A TH 152829 A TH152829 A TH 152829A TH 1401002360 A TH1401002360 A TH 1401002360A TH 1401002360 A TH1401002360 A TH 1401002360A TH 152829 A TH152829 A TH 152829A
- Authority
- TH
- Thailand
- Prior art keywords
- adrenomedulin
- polyethylene glycol
- treatment
- peg
- please love
- Prior art date
Links
- 239000002202 Polyethylene glycol Substances 0.000 title claims abstract 6
- 229920001223 polyethylene glycol Polymers 0.000 title claims abstract 6
- 238000011282 treatment Methods 0.000 claims abstract 4
- 229940079593 drug Drugs 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims abstract 3
- 238000011321 prophylaxis Methods 0.000 claims abstract 3
- 208000024172 Cardiovascular disease Diseases 0.000 claims abstract 2
- 206010061218 Inflammation Diseases 0.000 claims abstract 2
- 206010030113 Oedema Diseases 0.000 claims abstract 2
- 230000004054 inflammatory process Effects 0.000 claims abstract 2
- 238000004519 manufacturing process Methods 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 230000002917 arthritic effect Effects 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Abstract
DC60 (30/04/57) การประดิษฐ์เกี่ยวข้องกับโปรดรักฐาน พอลิเอทิลีน ไกลคอล (PEG) ใหม่ของอะดรีโนเมดูลลิน, กระบวนการสำหรับการเตรียมของมัน, การใช้ของมันสำหรับการรักษา และ/หรือ การป้องกันโรค, และการใช้ของมันสำหรับการผลิตยาสำหรับการรักษา และ/หรือ การป้องกันโรค, โดยเฉพาะอย่างยิ่ง ความผิดปกติหัวใจร่วมหลอดเลือด, จากอาการบวมน้ำ และ/หรือ จากการอักเสบ สิทธิบัตรยา DC60 (30/04/14) The invention involves please love the new polyethylene glycol (PEG) base of adrenomedulin, the process for its preparation, its use. For treatment and / or prophylaxis, and its use for the manufacture of medicines for the treatment and / or prophylaxis, in particular Cardiovascular disorders, from edema and / or from inflammation.
Claims (2)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH152829A true TH152829A (en) | 2016-06-07 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123476T1 (en) | NUCLEAR TRANSPORT MODIFIERS AND THEIR USES | |
| CY1122730T1 (en) | 1,2,4-TRIAZOLES AS NUCLEAR TRANSPORT MODULATORS AND THEIR USES | |
| EA201490152A1 (en) | TRPM8 ANTAGONISTS AND THEIR APPLICATION IN TREATMENT | |
| EA201301240A1 (en) | POLYMORPHIC FORMULA BENZOA LIGNOGLIPTINA | |
| CY1121825T1 (en) | A PHOSPHOINOSITIDE 3-KINASE INHIBITOR WITH A ZINC-BINDING MODULE | |
| CL2013003563A1 (en) | Compounds derived from gambogic acid amides and their salts; pharmaceutical composition comprising them, useful in the treatment of glioblastoma. | |
| MX380619B (en) | GLUTARIMIDE DERIVATIVES, THEIR USE, PHARMACEUTICAL COMPOSITION BASED ON THEM AND METHODS FOR PRODUCING GLUTARIMIDE DERIVATIVES. | |
| MY179605A (en) | Use of benzimidazole-proline derivatives | |
| CY1124115T1 (en) | THE USE OF GLYCERYL TRIBENZOIC CONTAINING COMPOSITION IN NEURODEGENERATE DISORDERS | |
| AR090806A1 (en) | GLUCOSIDS OF PIRAZOL AND ITS USE IN THE TREATMENT OF TYPE I AND II DIABETES | |
| EA201690621A1 (en) | POLYETHYLENE GLYCOL-CONTAINING COMPOSITIONS | |
| CL2015001881A1 (en) | Compound 4-hydroxy-2-methyl-5- (propan-2-ylidene) cyclohexyl-3-en-1-carbaldehyde; use of the compound for the treatment of Alzheimer's disease; pharmaceutical composition; Method to prepare the composition. | |
| MX380217B (en) | CXCR3 RECEPTOR AGONISTS. | |
| EA201500438A1 (en) | CRYSTALLINE PHASE (3S, 3S ') - 4,4'-DISULFANDIIL-BIS- (3-AMINOBUTAN-1-SULFO ACIDS) WITH L-LYSIN | |
| ES2405259B1 (en) | USE OF THE CHARMER (+) - C75 FOR THE TREATMENT OF OBESITY. | |
| TH166328A (en) | L-Coxipirae Sol is a soluble guanylate cyclase activator. | |
| TH153190A (en) | Benzamide derivatives for inhibition of the inactivation of ABL1, ABL2 and BCR-ABL1. | |
| TH1601004492A (en) | New tetrahydropyridopyrimidine compounds or their salts | |
| TH171902A (en) | Heterocyclic compounds | |
| TH134142A (en) | 2-Amino-3- (Imidazol-2-Il)-Piridin-4-Transfer Derivatives And its use as an inhibitor of VEGF receptor kinase | |
| TH158994A (en) | Carbocyclic nucleotide And pharmaceutical uses of these substances And composition | |
| TH146331A (en) | Inda Seoul | |
| TH167246A (en) | Biaryyl amide compounds As a kinase inhibitor | |
| TH160100A (en) | New compound and its pharmaceutical components for the treatment Cystic fibrosis | |
| TH154970A (en) | Aca indolene |